Skip to main content
SupplementScience

St. John's Wort — Research Profile

Herbal Extract

Reviewed by·PharmD, BCPS

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

St.

St. John's Wort is clinically proven to match SSRIs for mild-to-moderate depression with fewer side effects, working through multi-target neurotransmitter reuptake inhibition. At 900mg daily (standardized to 0.3% hypericin), it effectively treats depression, anxiety, and mood disorders — but has extensive, serious drug interactions that require careful screening.

Key Facts

What it is
A flowering plant (Hypericum perforatum) extract standardized to hyperforin and/or hypericin, acting as a broad-spectrum neurotransmitter reuptake inhibitor for mood support
Primary benefits
  • Matches SSRIs in efficacy for mild-to-moderate depression in meta-analyses
  • Fewer side effects and better tolerability than prescription antidepressants
  • Broad neurotransmitter modulation — serotonin, norepinephrine, dopamine, GABA
  • Reduces anxiety symptoms as secondary benefit
  • Well-studied safety profile (when drug interactions are properly screened)
Typical dosage
900mg/day in 3 divided doses (standardized to 0.3% hypericin or 3-5% hyperforin)
Evidence level
Strong
Safety profile
Caution Needed

Time to Effect

Hours
Days
Weeks
Months
2-6 weekstypical onset

Like pharmaceutical antidepressants, St. John's Wort requires 2-4 weeks for initial mood improvement and 4-6 weeks for full therapeutic effect. Do not assess efficacy before 4 weeks of consistent use at therapeutic dose. Some patients report mild mood lift within 1-2 weeks, but full antidepressant response requires sustained treatment. Treatment duration in clinical trials is typically 6-12 weeks.

What the Research Says

St. John's Wort has one of the strongest evidence bases of any herbal medicine. The Cochrane Collaboration's landmark review (Linde et al., 2008) analyzed 29 RCTs with 5,489 patients and concluded that St. John's Wort extracts are superior to placebo and comparable to standard antidepressants for mild-to-moderate major depression, with significantly fewer side effects. Gastpar et al. (2006) directly compared 900mg/day St. John's Wort to 20mg citalopram in a double-blind RCT, finding equivalent efficacy with better tolerability. Mechanistically, hyperforin is the primary active compound, inhibiting reuptake of five neurotransmitters (serotonin, norepinephrine, dopamine, GABA, glutamate) through TRPC6 channel activation — a unique mechanism not shared by any pharmaceutical antidepressant. However, St. John's Wort is also one of the most potent known inducers of CYP3A4 and P-glycoprotein, the drug-metabolizing systems responsible for clearing approximately 50% of all prescription medications. This creates an extensive and dangerous interaction profile. Moore et al. (2000) documented the scope of these interactions in The Lancet, and subsequent case reports have confirmed life-threatening consequences including organ transplant rejection, HIV treatment failure, and unplanned pregnancies. The German Commission E and the European Medicines Agency both approve St. John's Wort for mild-to-moderate depression, but require drug interaction screening.

Benefits of St. John's Wort

  • Mild-to-moderate depression treatment — The Cochrane Collaboration (Linde et al., 2008) analyzed 29 RCTs with 5,489 patients and concluded St. John's Wort extracts are superior to placebo and comparable to standard antidepressants for treating mild-to-moderate major depression, with significantly fewer adverse events leading to discontinuation
  • Comparable efficacy to SSRIs with better tolerability — Gastpar et al. (2006) conducted a 6-week double-blind RCT directly comparing 900mg/day St. John's Wort extract (STW 3-VI) to 20mg/day citalopram in 388 patients with moderate depression; both treatments were equally effective, but St. John's Wort had fewer side effects including less sexual dysfunction, nausea, and fatigue
  • Multi-target neurotransmitter modulation — Hyperforin, the primary active compound, inhibits reuptake of serotonin, norepinephrine, dopamine, GABA, and glutamate through activation of TRPC6 ion channels, providing broader neurotransmitter coverage than any single-mechanism SSRI; this may explain why some patients respond to SJW who failed SSRI monotherapy
  • Anxiety reduction — Kobak et al. (2005) demonstrated that St. John's Wort significantly reduced symptoms in patients with generalized social anxiety disorder, and multiple depression trials report anxiety symptom improvement as a secondary outcome
  • Seasonal affective disorder (SAD) support — Kasper (1997) reviewed evidence suggesting St. John's Wort's combined antidepressant and mild MAO-inhibiting properties make it particularly suited for winter depression, where serotonin and melatonin dysregulation play central roles
Did you know?

St.

Forms of St. John's Wort

St. John's Wort supplement forms compared by bioavailability and best use
FormBioavailabilityBest For
Standardized Extract (0.3% Hypericin)ModerateMost clinically studied form — the standard used in Cochrane and major RCTs; typically 300mg capsules taken 3x daily; hypericin standardization is the industry norm
Standardized Extract (3-5% Hyperforin)ModerateTargeting the primary active compound — hyperforin is the main antidepressant agent; more pharmacologically relevant standardization but less common commercially
Whole Herb / TeaLowMild mood support — traditional preparation; inconsistent active compound levels make dosing unpredictable; not recommended for clinical depression treatment

Dosage Recommendations

General recommendation: 900mg/day divided into 3 doses of 300mg, standardized to 0.3% hypericin (or 3-5% hyperforin)

Timing: Divide into 2-3 daily doses with meals to improve absorption and reduce GI discomfort; consistent daily timing helps maintain stable blood levels • Take with food for best absorption.

Dosage by Condition

Mild-to-moderate depression
900mg/day (300mg 3x daily) for 6-12 weeks minimumStrong
Moderate depression (higher dose)
1,200-1,800mg/day in clinical trials showing dose-responseModerate
Generalized anxiety / social anxiety
900mg/day (300mg 3x daily)Emerging
Seasonal affective disorder
900mg/day, often combined with light therapyEmerging
General mood and stress support
600-900mg/dayModerate

Upper limit: 1,800mg/day (used in some clinical trials; higher doses increase photosensitivity risk and drug interaction severity)

Our Top St. John's Wort Picks

As an Amazon Associate, we earn from qualifying purchases. Some links below are affiliate links — this doesn't affect our editorial independence or product ratings. How we evaluate products

Nature's Way Perika St. John's Wort
Nature's Way
Overall / ClinicalForm: TabletPrice: $0.90/day (3 tablets)
Buy Now on Amazon
Nature's Bounty St. John's Wort 300mg
Nature's Bounty
BudgetForm: CapsulePrice: $0.27/day (3 capsules)
Buy Now on Amazon
Healths Harmony St. John's Wort
Healths Harmony
Best Supply / Dual-ActionForm: CapsulePrice: $0.13/capsule
Buy Now on Amazon
Toniiq 1000mg Ultra High Strength St. John's Wort
Toniiq
Highest PotencyForm: CapsulePrice: $0.12/capsule
Buy Now on Amazon
Nature's Way St. John's Wort Premium Extract
Nature's Way
Trusted BrandForm: CapsulePrice: $0.40/day (3 capsules)
Buy Now on Amazon

Medication Interactions & Contraindications

Drug Interactions

SSRIs (Sertraline, Fluoxetine, Escitalopram)
major
Antidepressant
NEVER combine St. John's Wort with SSRIs. Both increase serotonin levels through different mechanisms, creating risk of serotonin syndrome — a potentially fatal condition causing hyperthermia, seizures, muscle rigidity, and cardiovascular collapse. Allow a 2-week washout period when switching between SJW and SSRIs. This is an absolute contraindication.
Oral Contraceptives (Ethinyl Estradiol, Levonorgestrel)
major
Contraceptive
St. John's Wort induces CYP3A4, significantly reducing blood levels of contraceptive hormones. Documented cases of breakthrough bleeding and unplanned pregnancies exist. Use a backup contraception method (barrier method) while taking SJW and for one month after stopping.
Warfarin
major
Anticoagulant
CYP induction by St. John's Wort reduces warfarin blood levels, decreasing anticoagulant effect and increasing risk of blood clots, stroke, or pulmonary embolism. Do not combine. If already combining, do not abruptly stop SJW — consult your anticoagulation clinic for supervised transition.
Cyclosporine / Tacrolimus
major
Immunosuppressant
CYP3A4 induction dramatically reduces immunosuppressant blood levels. Cases of acute organ rejection in transplant patients taking St. John's Wort are documented. This is an absolute contraindication in all transplant recipients.
HIV Antiretrovirals (Indinavir, Efavirenz)
major
Antiviral
St. John's Wort can reduce antiretroviral drug levels by 50-60% through CYP3A4 induction, risking viral rebound and drug resistance. This is an absolute contraindication in HIV-positive patients on antiretroviral therapy.
Digoxin
major
Cardiac Glycoside
P-glycoprotein induction by St. John's Wort reduces digoxin absorption and increases elimination, lowering blood levels by approximately 25%. This may cause loss of heart rhythm control. Monitor digoxin levels closely or avoid combination.
Benzodiazepines (Alprazolam, Midazolam)
moderate
Anxiolytic
CYP3A4 induction may reduce benzodiazepine blood levels, decreasing their effectiveness. Do not increase benzodiazepine dose to compensate. Discuss alternative anxiety management with your physician.

Who Should NOT Take This

Concurrent SSRI, SNRI, MAOI, or tricyclic antidepressant use(absolute)
Combining St. John's Wort with serotonergic antidepressants creates risk of serotonin syndrome — a potentially fatal emergency. This includes sertraline, fluoxetine, paroxetine, escitalopram, venlafaxine, duloxetine, amitriptyline, and all MAO inhibitors. A 2-week washout is required when switching.
Organ transplant (on immunosuppressants)(absolute)
CYP3A4 induction reduces cyclosporine and tacrolimus levels, with documented cases of acute organ rejection. St. John's Wort is absolutely contraindicated in all transplant recipients.
HIV/AIDS on antiretroviral therapy(absolute)
CYP3A4 induction reduces protease inhibitor and NNRTI levels by 50-60%, risking treatment failure and development of drug-resistant viral strains. This is an absolute contraindication.
Bipolar disorder(relative)
Like all antidepressants, St. John's Wort can trigger manic or hypomanic episodes in individuals with bipolar disorder. Use only under psychiatric supervision with mood stabilizer coverage.
Planned surgery (within 5 days)(relative)
St. John's Wort may interact with anesthetic agents and prolong the effects of some anesthetics through MAO inhibition. The American Society of Anesthesiologists recommends discontinuing SJW at least 5 days before surgery.

This information is for educational purposes only. Always consult your healthcare provider before starting or stopping any supplement, especially if you take prescription medications.

Side Effects and Safety

Safety profile: Caution Needed

Potential Side Effects

  • Photosensitivity — increased sensitivity to sunlight and UV radiation; can cause sunburn, rash, or blistering at standard doses in fair-skinned individuals; use sunscreen and avoid prolonged sun exposure
  • GI discomfort (nausea, dry mouth, diarrhea) — mild and usually transient; taking with food reduces incidence
  • Dizziness and headache — reported in 2-5% of clinical trial participants; typically resolves within first week
  • Vivid dreams or insomnia — due to neurotransmitter modulation; taking last dose with dinner (not bedtime) may help
  • Serotonin syndrome risk when combined with serotonergic drugs — potentially life-threatening; see drug interactions
  • Hypomania or mania in individuals with undiagnosed bipolar disorder — St. John's Wort can trigger manic episodes, as can all antidepressants

Drug & Supplement Interactions

  • SSRIs and SNRIs (sertraline, fluoxetine, venlafaxine) — NEVER combine; risk of serotonin syndrome, a potentially fatal condition
  • Oral contraceptives — St. John's Wort induces CYP3A4, reducing contraceptive hormone levels; breakthrough bleeding and unplanned pregnancies documented
  • Warfarin and anticoagulants — CYP induction reduces warfarin levels, decreasing anticoagulation and increasing clot risk
  • HIV antiretrovirals (indinavir, efavirenz, nevirapine) — CYP3A4 induction can reduce drug levels by 50-60%, risking treatment failure and viral resistance
  • Immunosuppressants (cyclosporine, tacrolimus) — CYP3A4 induction can cause acute organ rejection in transplant patients
  • Digoxin — P-glycoprotein induction reduces digoxin levels, potentially causing cardiac arrhythmia management failure
  • Theophylline, anti-seizure medications, chemotherapy agents — all metabolized by CYP3A4; levels reduced by SJW co-administration
Check St. John's Wort interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

Related Supplements

Frequently Asked Questions

Is St. John's Wort as effective as prescription antidepressants?

For mild-to-moderate depression, yes. The Cochrane Collaboration analyzed 29 clinical trials and concluded St. John's Wort matches standard antidepressants (SSRIs) in efficacy for this severity range, with fewer side effects and lower dropout rates. A direct head-to-head trial showed it matched citalopram (Celexa). However, for severe major depression, St. John's Wort has not been shown to be effective — pharmaceutical antidepressants are needed. It is a legitimate treatment option for mild-to-moderate depression, not a general replacement for all antidepressant therapy.

Can I take St. John's Wort with my antidepressant?

Absolutely not. Combining St. John's Wort with SSRIs (sertraline, fluoxetine, escitalopram), SNRIs (venlafaxine, duloxetine), MAOIs, or tricyclic antidepressants creates serious risk of serotonin syndrome — a potentially fatal condition causing high fever, seizures, muscle rigidity, and rapid heart rate. If you want to switch from an antidepressant to St. John's Wort (or vice versa), you must work with your physician and allow a 2-week washout period between stopping one and starting the other.

Why does St. John's Wort interact with so many drugs?

St. John's Wort powerfully induces (speeds up) two major drug-clearing systems in your body: the CYP3A4 enzyme and the P-glycoprotein transporter. Together, these systems metabolize or transport roughly 50% of all prescription drugs. When St. John's Wort activates them, your body clears these drugs faster, dropping their blood levels below therapeutic range. This is why it interacts with such a wide range of medications — from birth control pills to HIV drugs to blood thinners to immunosuppressants.

Does St. John's Wort affect birth control pills?

Yes — this is one of the most important interactions. St. John's Wort induces CYP3A4, which metabolizes the hormones in oral contraceptives faster than normal, reducing their blood levels. Documented consequences include breakthrough bleeding and unplanned pregnancies. If you take oral contraceptives and want to use St. John's Wort, use an additional barrier contraception method (condoms) while taking SJW and for at least one month after stopping.

How long does St. John's Wort take to work?

Like pharmaceutical antidepressants, St. John's Wort requires 2-4 weeks for initial mood improvement and 4-6 weeks for full therapeutic effect. This is because the neurotransmitter changes need time to downstream-regulate receptor sensitivity and gene expression. Do not judge its effectiveness before 4 weeks at the full 900mg daily dose. If no improvement after 6 weeks, it may not be effective for your specific situation.

Is St. John's Wort safe for anxiety?

Emerging evidence suggests it helps with anxiety, particularly as a secondary benefit in patients with comorbid depression and anxiety. One small RCT showed significant improvement in social anxiety disorder. However, the evidence base for anxiety alone is much smaller than for depression. If anxiety is your primary concern and you don't take medications that interact with SJW, it is a reasonable option to try under healthcare provider guidance. Standard dose is 900mg/day for 4-6 weeks.

Can St. John's Wort cause sun sensitivity?

Yes. Hypericin, one of the active compounds, is a photosensitizer that increases skin sensitivity to UV radiation. At standard supplemental doses (900mg/day), the risk is modest but real — particularly for fair-skinned individuals. Apply broad-spectrum sunscreen (SPF 30+) daily, wear protective clothing, and avoid prolonged sun exposure or tanning beds while taking St. John's Wort. The risk increases at higher doses (1,200-1,800mg/day).

Should I tell my doctor I am taking St. John's Wort?

Absolutely — this is critical. St. John's Wort interacts with more medications than almost any other supplement. Your physician and pharmacist need to know about SJW use to check for dangerous interactions with any current or newly prescribed medications. This includes before any surgery (anesthesia interactions exist), before starting any new prescription, and especially before starting any antidepressant, blood thinner, contraceptive, or immunosuppressant. Treat St. John's Wort as you would any prescribed medication for disclosure purposes.

Continue Reading

References

  1. Linde K, Berner MM, Kriston L (2008). St John's wort for major depression. Cochrane Database of Systematic Reviews. DOI PubMed
  2. Gastpar M, Singer A, Zeller K (2006). Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry. DOI PubMed
  3. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA (2000). St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proceedings of the National Academy of Sciences. DOI PubMed
  4. Muller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C (1998). Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. DOI PubMed
  5. Kobak KA, Taylor LV, Bystritsky A, Kohlenberg CJ, Greist JH, Tucker P, Warner G, Futterer R, Vapnik T (2005). St John's wort versus placebo in social phobia: results from a placebo-controlled pilot study. Journal of Clinical Psychopharmacology. DOI PubMed
  6. Rahimi R, Nikfar S, Abdollahi M (2009). Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. DOI PubMed